199 related articles for article (PubMed ID: 16339696)
1. Osteoporosis in beta-thalassemia: Clinical and genetic aspects.
Origa R; Fiumana E; Gamberini MR; Armari S; Mottes M; Sangalli A; Paglietti E; Galanello R; Borgna-Pignatti C
Ann N Y Acad Sci; 2005; 1054():451-6. PubMed ID: 16339696
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism analysis in the COLIA1 gene of patients with thalassemia major and intermedia.
Arisal O; Deviren A; Fenerci EY; Hacihanefioglu S; Ulutin T; Erkmen S; Buyru N
Haematologia (Budap); 2002; 32(4):475-82. PubMed ID: 12803121
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ICL670, a once-daily oral iron chelator in a phase III clinical trial of beta-thalassemia patients with transfusional iron overload.
Galanello R
Ann N Y Acad Sci; 2005; 1054():183-5. PubMed ID: 16339664
[TBL] [Abstract][Full Text] [Related]
4. The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis.
Morabito N; Russo GT; Gaudio A; Lasco A; Catalano A; Morini E; Franchina F; Maisano D; La Rosa M; Plota M; Crifò A; Meo A; Frisina N
Bone; 2007 Jun; 40(6):1588-94. PubMed ID: 17412659
[TBL] [Abstract][Full Text] [Related]
5. Low bone mineral density in adolescents with beta-thalassemia.
Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
[TBL] [Abstract][Full Text] [Related]
6. The impact of genotype on endocrine complications in thalassaemia major.
Skordis N; Michaelidou M; Savva SC; Ioannou Y; Rousounides A; Kleanthous M; Skordos G; Christou S
Eur J Haematol; 2006 Aug; 77(2):150-6. PubMed ID: 16800840
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in Iranian adolescents and young adults with beta-thalassemia major.
Shamshirsaz AA; Bekheirnia MR; Kamgar M; Pakbaz Z; Tabatabaie SM; Bouzari N; Pourzahedgilani N; Azarkeivan A; Hashemi SR; Moosavi F; Alebouyeh M; Vosough P; Kimiagar M; Shamshirsaz AA; Moradi M; Habibzadeh MR; Nobakhthaghighi N; Larijani B
Pediatr Hematol Oncol; 2007; 24(7):469-79. PubMed ID: 17786783
[TBL] [Abstract][Full Text] [Related]
8. Survival and complications in thalassemia.
Borgna-Pignatti C; Cappellini MD; De Stefano P; Del Vecchio GC; Forni GL; Gamberini MR; Ghilardi R; Origa R; Piga A; Romeo MA; Zhao H; Cnaan A
Ann N Y Acad Sci; 2005; 1054():40-7. PubMed ID: 16339650
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of polymorphism of bone metabolism genes and evaluation of the risk of osteopenia in cosmonauts].
Oganov VS; Baranov VS; Kabitskaia OE; Novikov VE; Bakulin AV; Moskalenko MV; Aseev MV; Voĭtulevich LV
Aviakosm Ekolog Med; 2010; 44(3):18-23. PubMed ID: 21033393
[TBL] [Abstract][Full Text] [Related]
10. Endocrine complications in patients with Thalassaemia Major.
Toumba M; Sergis A; Kanaris C; Skordis N
Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
[TBL] [Abstract][Full Text] [Related]
11. Use of hormone replacement therapy for correction of high turnover bone disease in hypogonadal β-Thalassemia major patients presenting with osteoporosis: comparison with idiopathic premature ovarian failure.
Chatterjee R; Katz M; Bajoria R
Hemoglobin; 2011; 35(5-6):653-8. PubMed ID: 22074125
[TBL] [Abstract][Full Text] [Related]
12. [Genetic background of osteoporosis].
Takács I; Lakatos P
Orv Hetil; 2003 Jul; 144(30):1467-72. PubMed ID: 14569676
[TBL] [Abstract][Full Text] [Related]
13. Genetic and acquired predisposing factors and treatment of osteoporosis in thalassaemia major.
Wonke B; Jensen C; Hanslip JJ; Prescott E; Lalloz M; Layton M; Erten S; Tuck S; Agnew JE; Raja K; Davies K; Hoffbrand AV
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():795-801. PubMed ID: 10091149
[TBL] [Abstract][Full Text] [Related]
14. Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major.
Pietrapertosa AC; Minenna G; Colella SM; Santeramo TM; Renni R; D'Amore M
Panminerva Med; 2009 Mar; 51(1):17-23. PubMed ID: 19352306
[TBL] [Abstract][Full Text] [Related]
15. Osteopenia in female beta-thalassemic patients.
Pafumi C; Roccasalva L; Pernicone G; Spanò G; Palumbo MA; Gregorio FD; Caruso-Nicoletti M; Conversano M; Cianci A; Palumbo G
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():989-91. PubMed ID: 10091181
[TBL] [Abstract][Full Text] [Related]
16. The genetics of osteoporosis.
Williams FM; Spector TD
Acta Reumatol Port; 2007; 32(3):231-40. PubMed ID: 17940498
[TBL] [Abstract][Full Text] [Related]
17. Bone disease in thalassaemia major: recent advances in pathogenesis and clinical aspects.
Skordis N; Toumba M
Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():300-6. PubMed ID: 21705982
[TBL] [Abstract][Full Text] [Related]
18. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
[TBL] [Abstract][Full Text] [Related]
19. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
Perifanis V; Vyzantiadis T; Tziomalos K; Vakalopoulou S; Garipidou V; Athanassiou-Metaxa M; Harsoulis F
Ann Hematol; 2007 Jan; 86(1):23-30. PubMed ID: 17013645
[TBL] [Abstract][Full Text] [Related]
20. A survey of haplotype variants at several disease candidate genes: the importance of rare variants for complex diseases.
Liu PY; Zhang YY; Lu Y; Long JR; Shen H; Zhao LJ; Xu FH; Xiao P; Xiong DH; Liu YJ; Recker RR; Deng HW
J Med Genet; 2005 Mar; 42(3):221-7. PubMed ID: 15744035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
